Continuation of Exercise Is Necessary to Inhibit High Fat Diet-Induced β-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Maesako, Masato ^a   Uemura, Kengo ^a,b   Iwata, Ayana ^a   Kubota, Masakazu ^a   Watanabe, Kiwamu ^a   Uemura, Maiko ^a   Noda, Yasuha ^a   Asada Utsugi, Megumi ^a   Kihara, Takeshi ^a   Takahashi, Ryosuke ^a   Shimohama, Shun ^c   Kinoshita, Ayae ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ishiki Hospital   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMNESIA; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; EXERCISE; FEMALE; LEARNING DISORDER; LIPID DIET; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; METABOLIC REGULATION; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; SPATIAL MEMORY; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DIET, HIGH-FAT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; MALE; MEMORY DISORDERS; MICE; PHYSICAL CONDITIONING, ANIMAL;

EID: 84883412703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072796     Document Type: Article

References (35)

1. Hardy J, Selkoe D, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297: 353-3562.
2. Sperling R, Aisen P, Beckett L, Bennett D, Craft S, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7: 280-292.
3. Bateman R, Xiong C, Benzinger T, Fagan A, Goate A, et al. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New Engl J Med. 367: 795-804.
4. Luchsinger J, Reitz C, Honig L, Tang M, Shea S, et al. (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 65: 545-551.
5. Whitmer R, (2007) The epidemiology of adiposity and dementia. Cur Alzheimer Res. 4: 117-122.
6. Craft S, (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 66: 300-305.
7. Ho L, Qin W, Pompl P, Xiang Z, Wang J, et al. (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J. 18: 902-904.
8. Lazarov O, Robinson J, Tang Y, Hairston I, Korade-Mirnics Z, et al. (2005) Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 120: 701-713.
9. Hu Y, Xu P, Pigino G, Brady S, Larson J, et al. (2010) Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1ΔE9 mice. FASEB J. 24: 1667-1681.
10. Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, et al. (2012) Environmental enrichment ameliorated high-fat diet-induced Aβ deposition and memory deficit in APP transgenic mice. Neurobiol Aging. 33: 1011 e11-23.
11. Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, et al. (2012) Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J Biol Chem. 287: 23024-23033.
12. Friedland R, Fritsch T, Smyth K, Koss E, Lerner A, et al. (2001) Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci U S A. 98: 3440-3445.
13. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K, (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 58: 498-504.
14. Buchman A, Boyle P, Yu L, Shah R, Wilson R, et al. (2012) Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 78: 1323-1329.
15. Mattson M, (2012) Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 16: 706-722.
16. Mucke L, Masliah E, Yu G, Mallory M, Rockenstein E, et al. (2000) High-level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 20: 4050-4058.
17. Rose J, Crews L, Rockenstein E, Adame A, Mante M, (2009) Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci. 29: 1115-1125.
18. Walsh D, Klyubin I, Fadeeva J, Cullen W, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid-β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416: 535-539.
19. Lesne S, Koh M, Kotilinek L, Kayed R, Glabe C, et al. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature. 440, 352-357.
20. Shankar G, Li S, Mehta T, Garcia-Munoz A, Shepardson N, et al. (2008) Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med. 14: 837-842.
21. Luchsinger J, Tang M, Shea S, Mayeux R, (2002) Caloric intake and the risk of Alzheimer disease. Arch Neurol. 59: 1258-1263.
22. Morris M, Evans D, Bienias J, Tangney C, Bennett D, et al. (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol. 60: 194-200.
23. Cao D, Lu H, Lewis T, Li L, (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem. 282: 36275-36282.
24. Julien C, Tremblay C, Phivilay A, Berthiaume L, Emond V, et al. (2010) High-fat diet aggravates amyloid-β and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging. 31: 1516-1531.
25. Xu W, Atti A, Gatz M, Pedersen N, Johansson B, et al. (2011) Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 76: 1568-1574.
26. Hiltunen M, Khandelwal V, Yaluri N, Tiilikainen T, Tusa M, et al. (2012) Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med. 16: 1206-1222.
27. De Felice F, (2013) Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J Clin Invest. 123: 531-539.
28. Li S, Jin M, Zhang D, Yang T, Koeglsperger T, et al. (2013) Environmental novelty activates β2-adrenergic signaling to prevent the impairment of hippocampal LTP by Aβ oligomers. Neuron. 77: 929-941.
29. Moreno-Gonzalez I, Estrada L, Sanchez-Mejias E, Soto C, (2013) Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. Nat Commun. 4: 1495.
30. Sharma R, Buras E, Terashima T, Serrano F, Massaad C, et al. (2010) Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice, PloS ONE. 5: e13463.
31. Shibata M, Yamasaki N, Miyakawa T, Kalaria R, Fujita Y, et al. (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke. 38: 2826-2832.
32. Serlin Y, Levy J, Shalev H, (2011) Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc Psychiatry Neurol. 2011: 609202.
33. Neeper S, Gomez-Pinilla F, Choi J, Cotman C, (1995) Exercise and brain neurotrophins. Nature. 373: 109.
34. Verret L, Krezymon A, Halley H, Trouche S, Zerwas M, et al. (2013) Transient enriched housing before amyloidosis onset sustains cognitive improvement in Tg2576 mice. Neurobiol Aging. 34: 211-225.
35. Meyer-Luehmann M, Spires-Jones T, Prada C, Garcia-Alloza M, de Calignon A, et al. (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature. 451: 720-724.